Sofosbuvir/ledipasvir and ribavirin tolerability and efficacy in pediatric liver transplant recipients

被引：6
|
作者：
Huysentruyt, Koen [1 ]
Stephenne, Xavier [1 ]
Varma, Sharat [1 ]
Scheers, Isabelle [1 ]
Leclercq, Gisele [2 ]
Smets, Francoise [1 ]
Sokal, Etienne M. [1 ]
机构：
[1] Catholic Univ Louvain, Clin Univ St Luc, Serv Gastroenterol & Hepatol Pediat, Ave Hippocrate 10, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Clin Univ St Luc, Serv Pharm Hosp, Brussels, Belgium
来源：
LIVER TRANSPLANTATION | 2017年 / 23卷 / 04期
关键词：
HEPATITIS-C VIRUS; INFECTION; CHILDREN;
D O I：
10.1002/lt.24692
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：552 / 553
页数：2
相关论文
共 50 条
  • [1] Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin
    Pillai, A. A.
    Maheshwari, R.
    Vora, R.
    Norvell, J. P.
    Ford, R.
    Parekh, S.
    Cheng, N.
    Patel, A.
    Young, N.
    Spivey, J. R.
    Mgbemena, O.
    Wedd, J. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) : 1427 - 1432
  • [2] SAFETY AND TOLERABILITY OF RECURRENT HEPATITIS C TREATMENT IN POST LIVER AND LIVER/KIDNEY TRANSPLANT PATIENTS TREATED WITH LEDIPASVIR/SOFOSBUVIR WITH AND WITHOUT RIBAVIRIN OR SOFOSBUVIR WITH RIBAVIRIN: SINGLE CENTER EXPERIENCE
    Selim, K.
    Elhazin, B.
    Long, W.
    Karmanova, M.
    Salazar, J.
    Volk, M.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S788 - S789
  • [3] The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data
    Pyrsopoulos, Nikolaos
    Trilianos, Panagiotis
    Lingiah, Vivek A.
    Fung, Phoenix
    Punnoose, Merlin
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (07) : 761 - 765
  • [4] Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients
    Levitsky, Josh
    Verna, Elizabeth C.
    O'Leary, Jacqueline G.
    Bzowej, Natalie H.
    Moonka, Dilip K.
    Hyland, Robert H.
    Arterburn, Sarah
    Dvory-Sobol, Hadas
    Brainard, Diana M.
    McHutchison, John G.
    Terrault, Norah A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2106 - 2108
  • [5] Sofosbuvir plus ledipasvir for recurrent hepatitis C in liver transplant recipients
    Altraif, Ibrahim Hamad
    [J]. LIVER TRANSPLANTATION, 2017, 23 (04) : 554 - 556
  • [6] The efficacy of Sofosbuvir/Ledipasvir or sofosbuvir/daclatasvir based therapies (with/without ribavirin) for recurrent hepatitis C (genotype 1,2) in liver transplantation recipients
    Hu, T. -H
    Chen, C. -L
    Lin, C. -C
    Lin, Y. -H
    [J]. TRANSPLANTATION, 2018, 102 : 113 - 113
  • [7] The effect of ledipasvir/sofosbuvir on dose-normalized levels of immunosuppression in liver transplant recipients
    Johnson, Heather
    Lichvar, Alicia B.
    Rustgi, Vinod K.
    [J]. HEPATOLOGY, 2015, 62 : 1057A - 1057A
  • [8] High Efficacy of Sofosbuvir/Ledipasvir Without Ribavirin in Patients With HCV Recurrence After Liver Transplantation
    Elfeki, Mohamed A.
    Abou Mrad, Rachel
    Esfeh, Jamak Modaresi
    Zein, Nizar N.
    Eghtesad, Bijan
    Hanouneh, Ibrahim A.
    Alkhouri, Naim
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S1098 - S1098
  • [9] Treatment of Hepatitis C with ledipasvir, sofosbuvir with or without ribavirin in post liver transplant patients in an academic center
    Pyrsopoulos, Nikolaos
    Lingiah, Vivek A.
    Sanaka, Sirish
    Fung, Phoenix
    Punnoose, Merlin
    [J]. HEPATOLOGY, 2016, 64 : 810A - 810A
  • [10] Sofosbuvir/Ledipasvir without Ribavirin is effective in the treatment of recurrent hepatitis C infection post liver transplant
    Shoreibah, Mohamed G.
    Jones, Deann
    Orr, Jordan
    Zhang, Jie
    Venkata, Krishna V.
    Massoud, Omar I.
    [J]. HEPATOLOGY, 2016, 64 : 995A - 996A
12345